Iovance Biotherapeutics (IOVA) Return on Equity [ROE] (2013 - 2026)
Iovance Biotherapeutics' Return on Equity [ROE] was -39.71% in Q2 2026, up 13.47 percentage points from -53.19% a year earlier and up 10.11 percentage points from the prior quarter.
Powered by 
Analysis
Iovance Biotherapeutics (IOVA) Return on Equity [ROE] (2013 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at Iovance Biotherapeutics came in at -55.49%, up 1.98 percentage points from FY2024.
- Return on Equity [ROE] shows a five-year change of -1.16 percentage points (FY2020 to FY2025).
- In earlier years, Return on Equity [ROE] was -57.48% in FY2024 (+24.42 pp), -81.90% in FY2023 (-11.29 pp), -70.61% in FY2022 (-17.06 pp) and -53.55% in FY2021 (+0.78 pp).
- The Q2 2026 figure marks the highest quarterly Return on Equity [ROE] since Q4 2020.
- Compared with a year earlier, Return on Equity [ROE] was higher in six of the last eight quarters, with an average year-over-year change of +8.68 percentage points.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q3 2023 (a gain of 20.87 percentage points); the worst was Q3 2022 (a drop of 46.85 percentage points).
- Per Business Quant data, IOVA's Return on Equity [ROE] in the three quarters before Q2 2026 was -49.83% (Q1 2026), -55.82% (Q4 2025) and -56.78% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Iovance Biotherapeutics | 6.44 Bn | 5.23 Bn | 55.72 Mn | -39.71% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -39.71% |
| Mar 31, 2026 | -49.83% |
| Dec 31, 2025 | -55.82% |
| Sep 30, 2025 | -56.78% |
| Jun 30, 2025 | -53.19% |
| Mar 31, 2025 | -50.78% |
| Dec 31, 2024 | -50.16% |
| Sep 30, 2024 | -53.17% |
| Jun 30, 2024 | -60.77% |
| Mar 31, 2024 | -71.10% |
| Dec 31, 2023 | -70.55% |
| Sep 30, 2023 | -69.13% |
| Jun 30, 2023 | -67.25% |
| Mar 31, 2023 | -70.58% |
| Dec 31, 2022 | -88.63% |
| Sep 30, 2022 | -90.00% |
| Jun 30, 2022 | -73.47% |
| Mar 31, 2022 | -61.08% |
| Dec 31, 2021 | -51.86% |
| Sep 30, 2021 | -43.16% |
API Access
Iovance Biotherapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IOVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "IOVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IOVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();